Oracle Investment Management Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Oracle Investment Management Inc

$43.2 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $68.2 Million - $120 Million	-820,470 Reduced 39.8%	1,240,932 $181 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $1.54 Million - $2 Million	-14,000 Reduced 0.67%	2,061,402 $244 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $4.85 Million - $7.22 Million	-48,653 Reduced 2.29%	2,075,402 $286 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $4.1 Million - $5.76 Million	41,500 Added 1.99%	2,124,055 $295 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $2.68 Million - $4.28 Million	-40,716 Reduced 1.92%	2,082,555 $202 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $1.6 Million - $2.29 Million	-25,000 Reduced 1.16%	2,123,271 $145 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $4.78 Million - $7.22 Million	73,471 Added 3.54%	2,148,271 $184 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $3.73 Million - $4.92 Million	63,100 Added 3.14%	2,074,800 $135 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $4.09 Million - $10.5 Million	140,957 Added 7.53%	2,011,700 $147 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $1.45 Million - $3.01 Million	-52,547 Reduced 2.73%	1,870,743 $63.7 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $5.86 Million - $8.27 Million	143,415 Added 8.06%	1,923,290 $105 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $4 Million - $5.29 Million	106,925 Added 6.39%	1,779,875 $74.3 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $25.9 Million - $43.7 Million	651,558 Added 63.79%	1,672,950 $73.3 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $29.2 Million - $45.1 Million	846,857 Added 485.21%	1,021,392 $52.6 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $5.19 Million - $7.49 Million	174,535 New	174,535 $6.45 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.

Account